Long‐Term Efficacy of Sublingual Immunotherapy in Patients With Perennial Rhinitis

Abstract

We suggest 3 years of sublingual immunotherapy for patients with perennial allergic rhinitis who require immunotherapy and do not accept the subcutaneous route of allergen administration.